GWave

Tel Aviv, Israel

GWave is a non-invasive continuous glucose monitoring technology solution.

$5.0M raised

Aug 2023

Series C

Top Investors

Columbia Pacific Advisors

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has GWave raised?

GWave has raised $5.0M in total funding. The most recent round was Series C. The last funding was announced in August 2023.

Who are GWave's investors?

GWave's investors include Columbia Pacific Advisors.

Where is GWave headquartered?

GWave is headquartered in Tel Aviv, Israel.

What does GWave do?

GWave is a non-invasive continuous glucose monitoring technology solution.

What stage is GWave at?

GWave is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 10, 2023.

MLA

"GWave — Funding & Investors." VCBacked, August 10, 2023, https://www.vcbacked.co/company/gwave. Accessed June 4, 2026.

APA

VCBacked. (2023). GWave — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/gwave

Wikipedia (cite web)

{{cite web |title=GWave — Funding & Investors |url=https://www.vcbacked.co/company/gwave |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 10, 2023.